Outpatient Total Joint Arthroplasty: The Shift to the ASC

Outpatient total joint arthroplasty — hip and knee replacement done as a same-day or short-stay procedure rather than a multi-day inpatient admission — is one of the most significant shifts in surgical operations of the past decade. Procedures that once meant three days in a hospital bed are now routinely sent home the same afternoon, and increasingly they happen in an ambulatory surgery center (ASC) rather than a hospital at all. This guide covers how that shift happened, the policy that enabled it, what the outcomes data actually shows, and why it turns OR efficiency from a nice-to-have into the central survival lever for surgery centers taking on these cases.

The migration is real and measurable. A Medicare analysis found that by 2022, ASCs performed about 8.6 percent of total joint arthroplasties (TJAs), part of a 327 percent surge in ASC TJA volume between 2019 and 2022. The direction is set; the open question for most leaders is no longer whether to do outpatient joints but how to do them profitably and safely.

How total joints became outpatient procedures

Two things had to be true before a knee replacement could go home the same day: the clinical pathway had to make it safe, and the payment rules had to make it possible.

The clinical side matured first. Better regional anesthesia, multimodal (and increasingly opioid-sparing) pain control, tranexamic acid to limit blood loss, and structured rapid-recovery protocols collectively shrank the recovery that used to require inpatient nursing. A practice-owned ASC series that migrated its total joints to the outpatient setting reported statistically significant improvements across hip and knee patient-reported outcome measures at six months alongside low complication rates — evidence that, done well, the outpatient pathway did not trade away results for speed.

What makes same-day discharge possible

The same-day pathway rests on a stack of advances that together replace what used to require days of inpatient nursing:

• Regional and spinal anesthesia that avoids the lingering grogginess of general anesthesia, so patients are alert and able to mobilize sooner.
• Multimodal, opioid-sparing analgesia that controls pain without the sedation and nausea that delay a safe discharge.
• Tranexamic acid and refined surgical technique that limit blood loss and its complications.
• Early mobilization and same-day physical therapy, so patients are walking before they leave the facility.
• Structured patient education and discharge planning that prepares the home setting and the caregiver in advance.

No single element turns a knee replacement into an outpatient procedure; the combination does. Remove one — inadequate pain control, say, or a home with no caregiver — and the pathway stalls. This is also why selection and the pathway are inseparable: the protocol assumes a patient who can actually use it.

What turned a clinical possibility into a market shift was policy.

The policy triggers

The regulatory mechanics are worth getting exactly right, because the two relevant Medicare lists are often conflated. The inpatient-only (IPO) list defines procedures Medicare will only pay for as inpatient admissions; removing a procedure from it opens the hospital outpatient pathway. The ASC covered-procedures list separately defines what Medicare will pay for in a freestanding ambulatory surgery center.

A retrospective cohort study examining how a new ASC affected a hospital's joint program documents this timeline. The sequence matters operationally: IPO removal opened the hospital outpatient department (HOPD) pathway first, and the ASC-list additions then opened the freestanding-ASC pathway a year or two later. Commercial payers, who often track Medicare's lead, accelerated the move.

The three settings, compared

Most of the cost-and-outcomes story is really about the difference between three settings — traditional hospital inpatient, hospital outpatient department (HOPD), and freestanding ASC — not a simple hospital-versus-ASC split.

What the outcomes data shows — and the selection caveat

This is the part to handle carefully, because it is the part most easily misread.

A Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) analysis of roughly 41,700 total joints compared 30- and 90-day outcomes across ASC, HOPD, and hospital settings. ASCs showed the lowest 30- and 90-day readmission and emergency-department visit rates of the three. Taken alone, that reads like "ASCs are safer."

The same study is explicit about why that conclusion would be wrong. ASC patients were, on average, younger, healthier, and more strictly selected — the hospital cohort included higher proportions of older patients, higher ASA class, obesity, diabetes, and other risk factors. The setting did not make those patients low-risk; they were chosen because they were low-risk. The outcomes reflect patient selection at least as much as the site of care.

Supporting cost-and-outcome work points the same way. An academic center's analysis of a short-stay surgical-care-unit pathway for outpatient TJA found shorter length of stay and modestly lower costs versus inpatient discharge, again in a selected population. The throughline across these studies is consistent: the outpatient model works when the patient is right for it. We dig into the safety question in depth in are ASCs safe for total joints?

Patient selection criteria for ASC joints

Because outcomes track selection, a disciplined, written selection protocol is the foundation of a safe program. Specific thresholds are set by each program's surgeons, anesthesiologists, and medical directors, but selection generally weighs:

• Age and physiologic reserve, rather than a single hard age cutoff.
• Body mass index, as a marker of perioperative and wound-complication risk.
• Cardiopulmonary and metabolic comorbidities — well-controlled versus poorly controlled diabetes, cardiac disease, sleep apnea, and similar.
• ASA physical status class, as a general summary of perioperative risk.
• Social support and home environment — a capable caregiver and a safe discharge setting, since recovery happens at home.

The point is not the specific list; it is that the list exists, is applied consistently, and is revisited as the program's own outcomes data comes in. A selection protocol that drifts case-to-case is the fastest way to convert a safe program into an unsafe one.

Common objections about ASC total joints

A few reasonable concerns come up whenever total joints move outpatient. The data does not dismiss them — it reframes them around selection.

• "Isn't it riskier without a hospital next door?" In appropriately selected patients, registry data shows low readmission and emergency-department rates. The safeguard is rigorous selection plus a clear escalation-and-transfer protocol — not physical proximity to an inpatient floor alone. An ASC doing joints should have its transfer agreement and emergency pathway defined before its first case.
• "What if a complication develops at home?" Structured patient education, scheduled follow-up, and explicit return precautions are what manage this, and the outcomes in selected populations are reassuring. Again, the control is selection: the protocol is built to send home only patients for whom home recovery is appropriate.
• "Do patients actually want same-day discharge?" The practice-owned ASC series cited above reported significant improvements in patient-reported outcomes at six months, suggesting that selected patients not only do well clinically but are satisfied with the experience. Many prefer recovering at home to a hospital stay.

The common thread in every answer is the same: a well-run ASC joints program is not safe despite skipping the inpatient stay — it is safe because it only takes patients for whom skipping it is appropriate, and because it has the protocols to handle the exceptions.

What the migration means for OR efficiency and scheduling

Here is where the financial logic turns operational. The same Medicare analysis that documented the volume surge also found that ASC reimbursement per total joint has been declining in real terms — an 8.1 percent drop after adjusting for inflation across the study period. So the ASC's structural cost advantage (estimated at roughly $235 million per year versus inpatient and $137 million versus HOPD at the population level) is being squeezed from the top line at the same time.

Falling per-case reimbursement plus rising volume has a clear implication: margin moves from the contract to the schedule. When you cannot raise the price, the only lever left is doing more, safely, with the same fixed block of staffed time. That is precisely the domain of the OR efficiency metrics that this whole blog is about — strong first case on-time starts, fast and safe turnovers, and disciplined block utilization. In a fixed-fee outpatient setting, a recovered minute is not an abstraction; it converts almost directly into protected margin or an additional case. We make the financial case in full in ASC total joint economics.

What it means for hospitals and ASCs

The migration reshapes the competitive landscape, not just individual programs. Hospitals lose their highest-margin elective volume as healthy patients move to lower-cost outpatient settings — which can leave the inpatient OR with an older, higher-acuity case mix, exactly the pattern the new-ASC cohort study examined. ASCs, meanwhile, gain volume but inherit the margin pressure of falling reimbursement. For both, the response is the same: the organization that runs its rooms most efficiently keeps the most of a shrinking per-case margin. Efficiency stops being an operational nicety and becomes the competitive moat.

How ORbit fits an outpatient joints program

This is the strategic reason a high-value ortho service line and an analytics platform belong in the same sentence. The clinical pathway gets the patient home safely; the efficiency metrics that actually matter decide whether the program makes money doing it. ORbit is built to make that second half visible — median-based on-time, turnover, and utilization analytics, scoped to your facility and broken out by surgeon and service line, plus a real-time day board for running the day — so an outpatient joints program can see exactly where its minutes (and its margin) are going.

If total joints are moving into your ASC, the schedule is where the economics are won or lost. The fastest way to find your own leak points is to see them on your own data.